Prevention and treatment of osteoporosis in women.
Osteoporosis affects one in three women. There has been some confusion among women and health professionals about the management of osteoporosis since the publication of the Women's Health Initiative and Million Women studies. This guidance regarding estrogen-based and non-estrogen-based treatments for osteoporosis responds to the controversies about the benefits and risks of individual agents. Treatment choice should be based on up-to-date evidence and targeted to individual women's needs.
Al-Azzawi
Farook
F
Barlow
David
D
Hillard
Tim
T
Studd
John
J
Williamson
Jenny
J
Rees
Margaret
M
D002136:Calcium, Dietary / Q000627:therapeutic use; D015914:Estrogen Replacement Therapy / Q000379:methods; D019317:Evidence-Based Medicine; D005260:Female; D050723:Fractures, Bone / Q000517:prevention & control; D017408:Guidelines as Topic; D006620:Hip Fractures / Q000517:prevention & control; D006801:Humans; D008593:Menopause / Q000187:drug effects; D010024:Osteoporosis / Q000188:drug therapy* / Q000517:prevention & control*; D014807:Vitamin D / Q000627:therapeutic use; D016387:Women's Health
D002136:Calcium, Dietary; D014807:Vitamin D